BTL Industries v. Doll Haus Aesthetics: EMSLIM NEO Infringement Action Voluntarily Dismissed
BTL Industries Inc filed a patent infringement action against Doll Haus Aesthetics and Honoree Treadwell in the Central District of California, asserting US10478634B2 over the EMSLIM NEO device. The case was voluntarily dismissed just 57 days after filing, with no merits adjudication on the public record.
Fast-exit infringement action: BTL Industries dismisses EMSLIM NEO suit in 57 days
On 16 October 2023, BTL Industries Inc filed a patent infringement action in the United States District Court for the Central District of California (Case No. 2:23-cv-08707) against Doll Haus Aesthetics and individual defendant Honoree Treadwell. The asserted patent is US10478634B2, and the accused product is the EMSLIM NEO, a device in the electromagnetic body-contouring and muscle-stimulation technology space.
The recorded basis of termination is voluntary dismissal. The docket order states that the dismissal was made pursuant to F.R.Civ.P. 41(a) or (c). The public record does not specify whether the dismissal was with or without prejudice, and the specific terms — if any — are not disclosed in the available record.
The case closed on 12 December 2023, just 57 days after filing. This compressed timeline suggests the matter concluded before substantive litigation milestones such as claim construction or discovery. What prompted the early exit — whether a private resolution, licensing arrangement, or other consideration — is not disclosed in the available public record.
See Complete Case & Patent Analysis →Filing to Voluntary dismissal in 57 days
Case resolved in 57 days — well below median patent litigation timelines in C.D. Cal.
US10478634B2 — electromagnetic muscle-stimulation device technology
Any company developing, importing, distributing, or operating electromagnetic muscle-stimulation or body-contouring devices — including EMSLIM NEO-adjacent products — should assess freedom to operate against US10478634B2. This case confirms BTL Industries is actively monitoring the market and willing to file infringement actions against both corporate entities and individual clinic operators.
Official order — verbatim text
The docket records the dismissal as made pursuant to F.R.Civ.P. 41(a) or (c), without specifying the prejudice status. This means no court has adjudicated the infringement, validity, or claim scope of US10478634B2 in this proceeding. The absence of a merits ruling leaves both parties' legal positions formally unchanged from the day the complaint was filed.
Voluntarily dismissed: what the early exit means for both parties
Rule 41 voluntary dismissal: what it means procedurally
A voluntary dismissal under F.R.Civ.P. 41(a) or (c) allows a plaintiff to exit the case without a court ruling on the merits. The case is terminated at the plaintiff's election rather than by adjudication. Whether the dismissal is with or without prejudice determines if BTL Industries may re-file the same claims — but the public record is silent on this point.
No merits rulingWith or without prejudice? The record is silent
A dismissal with prejudice bars the plaintiff from re-filing the same claims against the same defendants. A dismissal without prejudice preserves that option. The docket order references Rule 41(a) or (c) but does not specify which applies here. The public record does not clarify the prejudice status, and no further terms are disclosed.
Prejudice status unknownDefendants exit without a court finding of infringement or validity
Doll Haus Aesthetics and Honoree Treadwell face no court-entered judgment of infringement or liability. The dismissal does not constitute an admission by either party. If the dismissal is without prejudice, the defendants could face renewed litigation over the same patent and product. The specific terms agreed — if any — are not in the public record.
No liability findingUS10478634B2 remains enforceable; EMSLIM NEO market exposure persists
The voluntary dismissal leaves US10478634B2 in force with no validity challenge resolved. Competitors and distributors operating in the electromagnetic muscle-stimulation and body-contouring device market should note that BTL Industries' patent position is unchanged. The EMSLIM NEO dispute may signal active monitoring of the market by the patent holder.
Patent remains activeFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | BTL Industries Inc | Company | /Search in Eureka ↗ |
| Defendant | Doll Haus Aesthetics | Individual | /Search in Eureka ↗ |
| Co-Defendant | Honoree Treadwell | Individual | Search in Eureka ↗ |
| Plaintiff counsel | Randy R. Haj | Attorney | Counsel for BTL Industries IncSearch in Eureka ↗ |
| Plaintiff counsel | Seth R. Ogden | Attorney | Counsel for BTL Industries IncSearch in Eureka ↗ |
| Plaintiff law firm | Patterson Intellectual Property Law PC | Law Firm | Representing BTL Industries IncSearch in Eureka ↗ |
| Plaintiff law firm | Payne & Fears LLP | Law Firm | Representing BTL Industries IncSearch in Eureka ↗ |
| Presiding judge | Judge N/A | Judge | California Central District CourtSearch in Eureka ↗ |
R&D signals in the electromagnetic aesthetic-device space
Forward-looking patent and innovation intelligence derived from the BTL Industries v. Doll Haus Aesthetics dispute and the broader EMSLIM NEO technology landscape.
BTL Industries' filing activity in electromagnetic stimulation technology
BTL Industries holds US10478634B2 in the electromagnetic body-contouring space. Mapping BTL's broader US and international filing activity — including continuations, divisionals, and PCT applications — can reveal the extent of their IP perimeter around EMSLIM NEO and related devices, helping competitors identify design-around opportunities.
Portfolio mappingFiling trends in non-invasive electromagnetic body-contouring devices
The electromagnetic aesthetic-device sector has seen growing patent activity as non-invasive alternatives to surgical procedures expand. Tracking filing trends across IPC classes related to therapeutic electromagnetic stimulation can surface emerging competitors, technology white space, and the maturity of the patent thicket around devices like EMSLIM NEO.
Sector filing trendsHow competing aesthetic-device makers are positioning their IP
Competitors in the electromagnetic aesthetic-device market — including those offering high-intensity focused electromagnetic (HIFEM) and related technologies — are actively building patent portfolios. Analysing their claims alongside US10478634B2 can clarify the competitive IP landscape and inform R&D prioritisation for differentiated product development.
Competitive IP analysisAdjacent innovation opportunities near US10478634B2 claim scope
A claim-level analysis of US10478634B2 may identify adjacent technical approaches — such as multi-modal stimulation, wearable electromagnetic applicators, or AI-driven treatment protocols — that fall outside the current claim scope. These represent potential white-space opportunities for R&D teams seeking to enter the non-invasive body-contouring market without infringing BTL's asserted patent.
Innovation white spaceSimilar electromagnetic device patent cases in California federal courts
Explore comparable patent infringement actions involving electromagnetic therapeutic and aesthetic devices litigated in California's Central District Court.
What this case signals for the body-contouring device IP landscape
A 57-day voluntary dismissal in a device-patent infringement action raises questions about enforcement strategy and commercial resolution in the aesthetic-device sector.
Short-duration suits can signal rapid out-of-court resolution or deterrence
When a patent infringement action closes in under 60 days with no merits ruling, it consistently suggests either a swift private arrangement or a deterrence-and-exit strategy. Competitors and distributors in the EMSLIM NEO market should treat this filing as evidence of active enforcement activity by BTL Industries around US10478634B2.
Unresolved prejudice status leaves the door open for re-filing
Because the public record does not confirm whether the dismissal was with or without prejudice, Doll Haus Aesthetics and similarly positioned market participants cannot be certain that BTL Industries has permanently abandoned its infringement claims. Parties relying on EMSLIM NEO-adjacent technology should assess their exposure accordingly.
BTL v Doll — key questions answered
BTL Industries Inc filed a patent infringement action on 16 October 2023 in the Central District of California against Doll Haus Aesthetics and Honoree Treadwell, asserting US10478634B2 over the EMSLIM NEO device. The case was voluntarily dismissed 57 days later on 12 December 2023, pursuant to F.R.Civ.P. 41(a) or (c), with no merits adjudication recorded.
BTL Industries asserted US10478634B2 (application number US16/034793) in this action. The patent relates to the EMSLIM NEO product in the electromagnetic body-contouring and muscle-stimulation device space. No claim construction or validity ruling was issued in this proceeding.
The public record does not specify. The docket order states the dismissal was made pursuant to F.R.Civ.P. 41(a) or (c), but does not indicate whether it was with or without prejudice. The specific terms, if any, are not disclosed in the available record.
Honoree Treadwell was named alongside the corporate defendant Doll Haus Aesthetics. The inclusion of an individual defendant in a patent infringement action can suggest the plaintiff is pursuing personal liability theories, potentially against a clinic owner or operator. The complaint's specific allegations against Treadwell are not detailed in the available public record.
A voluntary dismissal within 57 days of filing — before substantive litigation milestones such as claim construction or discovery — typically signals that the matter resolved quickly outside of court, or that the plaintiff elected to exit for strategic reasons. The underlying drivers in this specific case are not disclosed in the available public record.
This page is compiled from public court dockets and third-party patent and litigation data via PatSnap Eureka, and is provided for general informational purposes only. The information shown — including party names, patent and application numbers, dates, case status, outcomes, and any analysis — may be incomplete, may not reflect the most recent filings or legal status, and may contain errors or omissions. Verify all details against official court records (for example, PACER) and the relevant patent office before relying on them.
Nothing on this page constitutes legal advice or a legal opinion on the validity, infringement, enforceability, or scope of any patent or case, and no attorney‑client relationship is created by its use. Any description of an outcome (such as a dismissal, settlement, or consent judgment) is a general summary, not a legal determination. All patents, trademarks, and company or law‑firm names are the property of their respective owners. PatSnap makes no warranty as to the accuracy or completeness of this content and disclaims, to the fullest extent permitted by law, all liability for reliance on it. For advice on a specific matter, consult qualified legal counsel.
PatSnap Eureka searches patents and litigation data to answer instantly.